Money.ca on MSN
How much does a new pet really cost in Canada? Here's what to budget for every expense in the first year
From vet bills and food to insurance and supplies, here's a full first-year budget breakdown ...
What Kind of Vents Are Best as a Floor Register MINNESOTA, MN, UNITED STATES, March 28, 2026 /EINPresswire.com/ -- ...
A fatal runway crash at New York's LaGuardia Airport left two pilots dead and dozens more injured and the airport closed on ...
When Harrison Gordon and Paige Sandher couldn't find a modular custom sofa that was also affordable, they designed their own.
One of the victims testified last week that she bought a mattress after Hennawi groped her but later got rid of it because she felt "icky" about sleeping on it.
Furniture manufacturer Foliot scales a cobot deployment to multiple plants for higher throughput, better operator retention ...
The audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. The Canadian ...
The thrilling Olympic final was one of the most-bet hockey games ever at DraftKings, but at least one Canadian operator was left torn following the contest. The U.S. men’s hockey team’s first Olympic ...
Public drug plans should not cover lecanemab, a drug to slow early-stage Alzheimer's disease, Canada's Drug Agency said Thursday in a draft recommendation. Lecanemab is a lab-made antibody given by ...
Add Yahoo as a preferred source to see more of our stories on Google. Canada's Drug Agency says a medication to slow early-stage Alzheimer’s disease should not be covered by public drug plans.
Hosted on MSN
Health matters: Public plans shouldn't cover Alzheimer's medication, Canada's drug agency says
Canada's Drug Agency says a medication to slow early-stage Alzheimer’s disease should not be covered by public drug plans. Lecanemab has been called the first disease-modifying Alzheimer’s treatment ...
Canada’s public drug plans should not pay for a new medication that slows cognitive decline in Alzheimer’s patients because it’s not clear the expensive therapy provides clinically meaningful benefits ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results